Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Al18F-HER2-BCH PET/CT to Predict Response in Breast Patients Treated With ADC Therapy

NCT06909604 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT06909604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06909604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Al18F-HER2-BCH PET/CT to Predict Response in Breast Patients Treated With ADC Therapy
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 30, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer